Cargando…
The key advance in the treatment of sepsis in the last 10 years ... doing less
Although many pharmaceutical and technological advances are heavily touted, they have had relatively little impact on overall outcome improvements in the critically ill. Acting on the increasing recognition that 'less may be best' has, in my opinion, been the greatest single advance in pat...
Autor principal: | Singer, Mervyn |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550797/ https://www.ncbi.nlm.nih.gov/pubmed/16542478 http://dx.doi.org/10.1186/cc4849 |
Ejemplares similares
-
ASRHR in Ethiopia: reviewing progress over the last 20 years and looking ahead to the next 10 years
por: Akwara, Elsie, et al.
Publicado: (2022) -
Commentary: The Ross procedure: Just do it, or less, or a loss?
por: Svensson, Lars G.
Publicado: (2021) -
Why aren't we practising homogenized medicine?
por: Singer, Mervyn
Publicado: (2007) -
Biomarkers in sepsis
por: Singer, Mervyn
Publicado: (2013) -
Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)